A Single Cycle of Intravenous Immunoglobulin as Adjuvant to Rituximab in Patients With Pemphigus: A Retrospective Cohort Study at a Tertiary Referral Center
Clinical trial NCT06949241 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06949241
- Sponsor
- Ruijin Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2019-12-01
- Primary completion
- 2026-02-02
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.